Primary Site >> Stomach Cancer

Gene >> H2AFX

  • 2004
  • 2012
  • 2013
  • 2014
  • 2015
  • 2017
  • 2018
Ref: Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells.
PMID: 15173094
 Ref: Pharmacologic synergy between dual phosphoinositide-3-kinase and mammalian target of rapamycin inhibition and 5-fluorouracil in PIK3CA mutant gastric cancer cells.
PMID: 22336586
 Ref: Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
PMID: 23271172
 Ref: Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
PMID: 25483095
 Ref: Oxaliplatin triggers necrosis as well as apoptosis in gastric cancer SGC-7901 cells.
PMID: 25767076
 Ref: Subcellular distribution of RAD23B controls XPC degradation and DNA damage repair in response to chemotherapy drugs.
PMID: 28473198
 Ref: MicroRNA-196b enhances the radiosensitivity of SNU-638 gastric cancer cells by targeting RAD23B.
PMID: 29864624
Ref: Expression of oxidized protein tyrosine phosphatase and gammaH2AX predicts poor survival of gastric carcinoma patients.
PMID: 30126387